Polygonatum cyrtonema lectin, a potential antineoplastic drug targeting programmed cell death pathways

详细信息    查看全文

• 作者：Shu-ya Wang¹ ; ^a ; Qi-jia Yu¹ ; ^a ; Jin-ku Bao ; ^a ; ^{jinkubao@yahoo.com} ; Bo Liu ; ^a ; ^{liubo2400@163.com}
• 关键词：Polygonatum cyrtonema lectin (PCL) ; Plant lectin ; Programmed cell death (PCD) ; Apoptosis ; Autophagy
• 刊名：Biochemical and Biophysical Research Communications
• 出版年：2011
• 出版时间：25 March 2011
• 年：2011
• 卷：406
• 期：4
• 页码：497-500
• 全文大小：806 K

文摘

Polygonatum cyrtonema lectin (PCL), a mannose/sialic acid-binding plant lectin, has recently drawn a rising attention for cancer biologists because PCL bears remarkable anti-tumor activities and thus inducing programmed cell death (PCD) including apoptosis and autophagy in cancer cells. In this review, we focus on exploring the precise molecular mechanisms by which PCL induces cancer cell apoptotic death such as the caspase-dependent pathway, mitochondria-mediated ROS–p38–p53 pathway, Ras–Raf and PI3K–Akt pathways. In addition, we further elucidate that PCL induces cancer cell autophagic death via activating mitochondrial ROS–p38–p53 pathway, as well as via blocking Ras–Raf and PI3K–Akt pathways, suggesting an intricate relationship between autophagic and apoptotic death in PCL-induced cancer cells. In conclusion, these findings may provide a new perspective of Polygonatum cyrtonema lectin (PCL) as a potential anti-tumor drug targeting PCD pathways for future cancer therapeutics.